In last trading session, Unicycive Therapeutics Inc (NASDAQ:UNCY) saw 3.53 million shares changing hands with its beta currently measuring 2.01. Company’s recent per share price
Unicycive Therapeutics Inc (NASDAQ:UNCY) has a beta value of 2.00 and has seen 2.87 million shares traded in the last trading session. The company, currently
In the last trading session, 0.47 million shares of the Unicycive Therapeutics Inc (NASDAQ:UNCY) were traded, and its beta was 2.02. Most recently the company’s
In last trading session, Unicycive Therapeutics Inc (NASDAQ:UNCY) saw 1.17 million shares changing hands with its beta currently measuring 1.99. Company’s recent per share price
Unicycive Therapeutics Inc (NASDAQ:UNCY) has a beta value of 2.11 and has seen 0.38 million shares traded in the recent trading session. The company, currently
Unicycive Therapeutics Inc (NASDAQ:UNCY)’s traded shares stood at 0.48 million during the last session, with the company’s beta value hitting 2.13. At the close of
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne